- Home
- Articles
- latamerica
- patient survival
Refine by
Patient Survival Articles & Analysis
35 articles found
There is a pressing need for alternative precision medicine solutions to better characterize patients for individualized treatment decisions. If clinicians could better define the prognosis for these patients, their clinical management, monitoring, and systemic treatment decisions could be optimized to improve survival outcomes. To address this ...
Additionally, adenosine binds to the A2B receptor expressed by cancer cells themselves, facilitating tumor cell survival and proliferation. Further complexity arises as cancer cells also express the adenosine A1 receptor (ADORA1) and A3 receptor (ADORA3). ...
Having CPR skills enables these professionals to give immediate care until medical professionals come. This helps improve survival rates in emergencies. Flight Attendants and Cabin Crew Flight attendants are responsible for the safety and well-being of passengers on board. ...
Identifying HRD becomes crucial in guiding drug therapy and monitoring patient prognosis. In one study, WES analysis of 9321 patients with colorectal cancer (CRC) revealed that 13.6% of cases were HRD positive, demonstrating higher incidence in MSI tumors compared to MSS tumors. The study also found that overall survival was longer in ...
The Value of VEGF in Tumor Screening Most tumor patients are diagnosed in the middle to late stages, and early screening and timely diagnosis of suspicious or asymptomatic patients can improve the survival rate of tumor patients and prolong their overall survival. ...
Although more drug choices such as pertuzumab and lapatinib on the basis of trastuzumab significantly prolong the survival of patients and further improve the prognosis, many patients are not sensitive to treatment and relapse and drug resistance occur in a short time, and the efficacy of traditional HER2-targeted drugs for breast cancer ...
The development and marketing of new drugs have far-reaching significance in improving the survival of breast cancer patients and changing the pattern of breast cancer treatment. ...
However, through a large number of clinical studies, it was found that it could not improve the survival rate of patients, and had extremely serious side effects, so it was withdrawn from the market in 2010. ...
Medical History Jane is a 40-year-old, married mother of two teenage boys. She teaches at the local elementary school and has been in good health for most of her life. She has no surgical history. Her most severe ailment up to this point has been the flu at age 27. Her students are first-graders; they are often difficult to control. She also experiences the normal stresses of raising ...
In recent years, the application of targeted therapies has significantly prolonged the survival of patients. However, drug resistance, brain metastases, and other problems have become increasingly prominent in clinical practice. ...
Materials and Methods We analyzed gene expression in frozen lung cancer tissue from 59 selected patients who had undergone surgical resection of NSCLC. These patients were divided into two groups: group R, patients who had a tumor recurrence within four years, n=37; group NR, patients who remained disease-free four years ...
We excluded patients who had follow up time less than 3 years or received adjuvant therapy and had not had a recurrence, as well as patients with missing specimen blocks. ...
Pancreatic cancer is a highly malignant digestive system tumor, and the five-year survival rate of patients after diagnosis is only about 10%. Changes in metabolism are one of the important features of tumor cells. ...
Background Pancreatic cancer is one of the highest mortality rate cancers worldwide with 5-year relative survival of 10.8%. Lack of screening methods for early-stage detection as well as proper patient sub-characterization, make it a fatal cancer due to poor diagnoses and insufficient treatment. ...
The hazard ratio (80% confidence interval) for overall survival (OS) time for patients in the study group versus those in the standard-of-care group was 0.69 (0.51-0.92). ...
At present, chimeric antigen receptor T cell therapy (CAR-T) has made significant achievements in the treatment of specific hematological cancers, allowing patients with relapsed/refractory disease to survive longer and become healthier, but in clinical studies, cell therapy has actually not been successful in the treatment of patients with solid ...
There’s been a huge emphasis on developing new treatments to improve survival in patients with cancer, but these trials have become a costly undertaking for sponsor companies. ...
The key to this patient's recovery was a blood stem cell transplant: The researchers first used chemotherapy drugs to kill the patient's own immune cells and then transplanted new cells that would not be infected by HIV. ...
The advent of immune checkpoint inhibitors (ICI) has improved the overall survival of patients with a variety of malignancies. However, the problem of drug resistance to ICI therapy remains a major obstacle limiting its clinical application. ...
The reason for this dynamic is as follows: with the increasing clinical effectiveness of the pDVA strategy, improved survival leads to greater healthcare resource utilization among pDVA patients—resulting in costs that patients in the status quo cohort would not incur because of their earlier death. In the base case, the same dynamic can ...